Refine your search
-
Authors
-
Item types
-
Topics
- *Acetamides/ec [Economics]
- *Cross Infection/dt [Drug Therapy]
- *Cross Infection/ec [Economics]
- *Linezolid/ad [Administration & Dosage]
- *Methicillin-Resistant Staphylococcus aureus
- *Models, Economic
- *Oxazolidinones/ec [Economics]
- *Pneumonia, Staphylococcal/dt [Drug Therapy]
- *Pneumonia, Staphylococcal/ec [Economics]
- *Vancomycin/ad [Administration & Dosage]
- *Vancomycin/ec [Economics]
- Acetamides/ad [Administration & Dosage]
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents/ad [Administration & Dosage]
- Anti-Bacterial Agents/ec [Economics]
- Cost-Benefit Analysis/mt [Methods]
- Double-Blind Method [x]
- Humans
- Show more
- Show less
-
Collections
-
Languages